Follow the SPIMACO stock price and the full directors' dealings record of the company, a listed issuer based in Saudi Arabia. Shares are quoted on SA SA, under the supervision of Tadawul (CMA). Operating in the Health Care sector, SPIMACO has published 4 reports. Market capitalisation: €3.4bn. The latest transaction was reported on 24 November 2024 (Board / executive change). All data is openly available.
Analysts rate SPIMACO Hold (neutral), based on 3 analysts. Average price target: SAR 31.20.
Transparent value + quality ranking, distinct from the insider signal.
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.